Compare Chainbase (C) vs Immunefi (IMU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Chainbase vs Immunefi — how do they compare? Chainbase trades at Rp1,138 (market cap Rp412,31M, Rp81,37M 24h volume), while Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume). The key difference: Chainbase is far larger — about 15.3× Immunefi's market cap, and Chainbase's circulating supply is 362,6M / 1B C (37%) versus 873,4M / 10B IMU (9%) for Immunefi. Which is the better fit depends on your goals — on Pluang, investors hold Chainbase for 9 Days and Immunefi for 5 Days on average.
| C | IMU | |
|---|---|---|
Market Cap | Rp412,31M | Rp27,03M |
Volume (24h) | Rp81,37M | Rp39,91M |
Circulating Supply | 362,6M / 1B C (37%) | 873,4M / 10B IMU (9%) |
Typical Hold Time | 9 Days | 5 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Chainbase token is currently trading at Rp1,163.11 with a market cap of Rp416.72 million, showing bearish technical signals across multiple indicators. The asset faces selling pressure with 14 sell signals versus 4 buy signals, though oscillators remain neutral. With only 37% of the maximum 1 million token supply in circulation and an average hold time of 9 days, the token exhibits limited distribution and relatively short-term holding patterns.
Overall outlook remains cautious with technical weakness dominating. Key opportunities include potential accumulation at support levels, while major risks include low liquidity, bearish momentum, and limited network adoption. Investors should monitor for protocol developments and exchange liquidity improvements.
Immunefi token shows limited market activity with a modest market cap of Rp27,03M and only 9% circulating supply. The 5-day average hold time suggests short-term trading patterns dominate. Trading volume appears minimal based on available metrics, indicating low liquidity. No recent protocol updates or significant ecosystem developments were identified in crypto-specific sources.
Overall outlook remains cautious due to extremely low circulation rate and limited market presence. Key opportunity lies in potential future token utility development, while major risks include extreme volatility from low liquidity and regulatory uncertainty common to emerging crypto projects.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Chainbase
Chainbase is developing the Hyperdata Network for AI, establishing a foundational layer for the DataFi era. This network converts fragmented on-chain signals into structured, verifiable, and AI-ready data, facilitating seamless collaboration among agents, applications, and humans. Chainbase empowers a decentralized data economy where data is treated as capital—composable, monetizable, and accessible to everyone.
Read more on C →About Immunefi
Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →
